Zeo ScientifiX, Inc.

ZEOX · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
203
SEC Filings
$2.04
Close 2026-06-01

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company has a portfolio of proprietary products derived from ethically sourced birth tissue, including mesenchymal stem cells, stem cell and amniotic fluid derived exosomes and Whartons Jelly matrix. The Companys principal product is Zofin, a product derived from amniotic fluid a...

Latest Stock Quote

ZEOX 2026-06-01 $2.04 O:$1.8 H:$2.28 L:$1.71 Vol:0.0M VWAP:$1.8843
origin leaf: 17c597f55c68fc9c43b75f85b3779fc593c83bde0206b6e8f7c697bb3c8102e8

Next Earnings

Q2 FY2026 — expected 2026-07-19

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-01-292025-10-310001829126-26-000763EDGAR65K words
2025-01-292024-10-310001829126-25-000536EDGAR—
2024-01-292023-10-310001829126-24-000541EDGAR—
2023-02-142022-10-310001829126-23-001524EDGAR—
2022-02-142021-10-310001829126-22-003605EDGAR—
2021-02-082020-10-310001829126-21-000414EDGAR—
2020-10-162019-10-310001683168-20-003466EDGAR—
2020-03-062018-10-310001683168-20-000712EDGAR—
2018-11-012017-10-310001683168-18-003206EDGAR—
2017-07-072016-10-310001493152-17-007610EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-172026-01-310001829126-26-002396EDGAR17K words
2025-09-152025-07-310001829126-25-007398EDGAR—
2025-06-162025-04-300001829126-25-004512EDGAR—
2025-03-172025-01-310001829126-25-001828EDGAR—
2024-09-162024-07-310001829126-24-006296EDGAR—
2024-06-142024-04-300001829126-24-004217EDGAR—
2024-03-182024-01-310001829126-24-001677EDGAR—
2023-09-142023-07-310001829126-23-006098EDGAR—
2023-06-162023-04-300001829126-23-004245EDGAR—
2023-03-172023-01-310001829126-23-002113EDGAR—
2022-09-142022-07-310001829126-22-016867EDGAR—
2022-06-142022-04-300001829126-22-013532EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001829126-26-002881EDGAR1K words
2026-03-270001829126-26-002789EDGAR—
2026-01-280001829126-26-000610EDGAR—
2026-01-210001829126-26-000431EDGAR—
2026-01-070001829126-26-000073EDGAR—
2026-01-050001829126-26-000029EDGAR—
2025-12-030001829126-25-009662EDGAR—
2025-10-230001829126-25-008357EDGAR—
2025-07-290001829126-25-005526EDGAR—
2025-07-210001829126-25-005232EDGAR—

203 total filings indexed. 171 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001557376
TickerZEOX
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 168cfeaabdc522dcf02eb9cb01f74716f05263a5211622147a1638ba2bce638f
parent: 1a47099f2caf272ee5b4b54bf95a3985d7d2a0f4da4b0177a4515ebe639fb2a2
content hash: 8c158366ab8b6b4d2d6d10d6ffc3422446b41ea3d6989cd9d33add29fba78acc
signed: 2026-06-02T19:03:13.752Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf